Published in J Virol on July 01, 1973
Transfection of Enterobacteriaceae and its applications. Microbiol Rev (1978) 3.33
Transformation and transfection in lysogenic strains of Bacillus subtilis: evidence for selective induction of prophage in competent cells. J Bacteriol (1975) 2.80
Bacteriophages of Bacillus subtilis. Bacteriol Rev (1975) 2.77
Fragmentation of Bacillus bacteriophage phi105 DNA by complementary single-stranded DNA in the cohesive ends of the molecule. J Virol (1977) 1.42
Relationship between lysogeny, spontaneous induction, and transformation efficiencies in Bacillus subtilis. J Bacteriol (1974) 1.28
DNA-mediated prophage induction in Bacillus subtilis lysogenic for phi 105c4. J Virol (1973) 0.95
Segregation of New Lysogenic Types during Growth of a Doubly Lysogenic Strain Derived from Escherichia Coli K12. Genetics (1954) 18.73
Genetic Studies of Lysogenicity in Escherichia Coli. Genetics (1953) 10.25
Mutations in a temperate bacteriophage affecting its ability to lysogenize Escherichia coli. Virology (1957) 8.66
[System of repression insuring immunity in lysogenic bacteria]. C R Hebd Seances Acad Sci (1959) 3.84
INDUCIBLE PHAGES OF BACILLUS SUBTILIS. Biochemistry (1964) 3.62
Mapping of a temperate bacteriophage active on Bacillus subtilis. J Virol (1969) 3.34
Comparison of ultraviolet sensitivity of Bacillus subtilis bacteriophage SPO2 and its infectious DNA. J Mol Biol (1965) 3.12
Properties of the defective phage of Bacillus subtilis. J Mol Biol (1968) 3.09
Characterization of Temperate Bacillus Bacteriophage phi105. J Virol (1969) 2.14
The influence of temperate bacteriophage phi105 on transformation and transfection in Bacillus subtilis. Biochem Biophys Res Commun (1972) 2.08
Linked transformation of bacterial and prophage markers in Bacillus subtilis 168 lysogenic for bacteriophage phi 105. J Bacteriol (1969) 1.80
INCORPORATION OF BACTERIOPHAGE GENOME BY SPORES OF BACILLUS SUBTILIS. J Bacteriol (1964) 1.61
Heat induction of prophage phi 105 in Bacillus subtilis: replication of the bacterial and bacteriophage genomes. J Virol (1971) 1.38
Genetic mapping of a defective bacteriophage on the chromosome of Bacillus subtilis 168. J Virol (1970) 1.23
Studies with hydroxyurea. I. The reversible inhibition of bacterial DNA synthesis and the effect of hydroxyurea on the bactericidal action of streptomycin. Biochim Biophys Acta (1966) 2.42
Fragmentation of Bacillus bacteriophage phi105 DNA by complementary single-stranded DNA in the cohesive ends of the molecule. J Virol (1977) 1.42
Defective bacteriophages. J Cell Physiol (1970) 1.33
Correlated genetic and EcoRI cleavage map of Bacillus subtilis bacteriophage phi105 DNA. J Virol (1978) 1.28
Relationship between lysogeny, spontaneous induction, and transformation efficiencies in Bacillus subtilis. J Bacteriol (1974) 1.28
Isolation and characterization of prophage mutants of the defective Bacillus subtilis bacteriophage PBSX. J Virol (1975) 1.27
Genetic mapping of a defective bacteriophage on the chromosome of Bacillus subtilis 168. J Virol (1970) 1.23
Bacterial fusion assayed by a prophage complementation test. J Bacteriol (1979) 1.07
Microsomal metabolism of dimethylnitrosamine and the cytochrome P-450 dependency of its activation to a mutagen. Cancer Res (1973) 1.07
Expression of superinfection immunity to bacteriophage phi 105 by Bacillus subtilis cells carrying a plasmic chimera of pUB110 and EcoRI fragment F of phi 105 DNA. J Virol (1980) 1.01
Alcohol-related diseases and carcinogenesis. Cancer Res (1979) 1.00
DNA-mediated prophage induction in Bacillus subtilis lysogenic for phi 105c4. J Virol (1973) 0.95
Bacteriophage-specific protein synthesis during induction of the defective Bacillus subtilis bacteriophage PBSX. J Virol (1975) 0.92
Mutagenic activity of styrene oxide (1,2-epoxyethylbenzene), a presumed styrene metabolite. Mutat Res (1976) 0.91
In vitro and in vivo inhibitory effect of ethanol and acetaldehyde on O6-methylguanine transferase. Carcinogenesis (1988) 0.89
Enhanced pulmonary and intestinal activation of procarcinogens and mutagens after chronic ethanol consumption in the rat. Eur J Clin Invest (1981) 0.85
Vinyl chloride dependent mutagensis: effects of liver extracts and free radicals. Mutat Res (1976) 0.83
Enhancement of dimethylnitrosamine metabolism and activation to a mutagen following chronic ethanol consumption. Cancer Res (1981) 0.81
Association of the recombination-deficient phenotype of Bacillus subtilis recC strains with the presence of an SPO2 prophage. J Bacteriol (1976) 0.80
Effects of chronic ethanol consumption on carcinogen activating and detoxifying systems in rat upper alimentary tract tissue. Alcohol Clin Exp Res (1989) 0.80
Urinary mutagen levels in smokers. Cancer Lett (1983) 0.78
Effects of cytochrome p-448 and p-450 inducers on microsomal dimethylnitrosamine demethylase activity and the capacity of isolated microsomes to activate dimethylnitrosamine to a mutagen. Mutat Res (1976) 0.77
Cytochrome P-450 in the activation and inactivation of carcinogens. Adv Exp Med Biol (1975) 0.76
Effect of chronic ethanol ingestion on intestinal metabolism and mutagenicity of benzo(alpha)pyrene. Biochem Biophys Res Commun (1978) 0.76
The effects of chronic ethanol consumption on carcinogen metabolism and on O6-methylguanine transferase-mediated repair of alkylated DNA. Alcohol Clin Exp Res (1986) 0.76
Mutagenicity of the halogenated olefin, 2-bromo-2-chloro-1,1-difluoroethylene, a presumed metabolite of the inhalation anesthetic halothane. Environ Health Perspect (1977) 0.75
IONIC EFFECTS ON LIGNIFICATION AND PEROXIDASE IN TISSUE CULTURES. J Cell Biol (1965) 0.75
Chronic ethanol consumption inhibits repair of dimethylnitrosamine-induced DNA alkylation. Biochem Biophys Res Commun (1988) 0.75
Cytochrome P-450 content and the ability of liver microsomes from patients undergoing abdominal surgery to alter the mutagenicity of a primary and secondary carcinogen. J Natl Cancer Inst (1973) 0.75
Alcohol metabolism in the upper digestive tract: its implications with respect to carcinogenesis. Eur J Cancer Prev (1992) 0.75
Mutagenic activity in gastric juice and urine of subjects with chronic atrophic gastritis, gastric epithelial dysplasia and gastric cancer. Cancer Lett (1989) 0.75
Chronic ethanol feeding alters the structure and function of the epidermal growth factor receptor in rat stomach. Alcohol (1997) 0.75
Effect of chronic ethanol consumption on activation of nitrosopyrrolidine to a mutagen by rat upper alimentary tract, lung, and hepatic tissue. Drug Metab Dispos (1985) 0.75
Sex dependent effect of chronic ethanol consumption in rats on hepatic microsome mediated mutagenicity of benzo[a]pyrene. Cancer Lett (1981) 0.75
Mutagenicity of primary and secondary carcinogens altered by normal and induced hepatic microsomes. Proc Soc Exp Biol Med (1973) 0.75
Chronic anesthetic exposure--what is the margin of safety? Anesthesiology (1979) 0.75
Factors affecting the induction of dimethylnitrosamine demethylase by Aroclor 1254. Cancer Res (1977) 0.75
Pyrimidine-specific antibodies: reaction with DNA's of differing base compositions. J Immunol (1971) 0.75
Mutagenicity of the halogenated olefin, 2-bromo-2-chloro-1,1-difluoroethylene, a presumed metabolite of the inhalation anesthetic halothane. Mutat Res (1978) 0.75
Detection of mutagen-induced lesions in isolated DNA by marker rescue of Bacillus subtilis phage phi 105. Mutat Res (1980) 0.75